About Retatrutide (GLP-3) 20mg
Retatrutide (GLP-3) 20mg is a synthetic triple receptor agonist peptide studied in preclinical and clinical research for its interactions with GLP-1, GIP, and glucagon receptors (GLP-1/GIP/GCGR), including receptor binding and downstream signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Research Background
Retatrutide has been investigated in peer-reviewed studies examining triple incretin receptor binding affinity, pancreatic signaling modulation, and associated metabolic pathway mechanisms. The references below are provided for informational purposes and relate to published scientific literature.
PMID: 38356208
PMID: 37366315
PMID: 37902090
Product Specifications
- Classification: Triple GLP-1/GIP/GCGR receptor agonist peptide
- Content: 20mg per vial Purity: 99%+ verified by LC-MS
- Format: Lyophilized powder Storage: Store at -20°C, protected from light
- CAS Number: 2381306-68-7
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled only by licensed, qualified professionals in a controlled laboratory setting.
Research Resources
- What Is Retatrutide?
- Retatrutide vs. Tirzepatide GLP-1
- Receptor Biology Guide
For research purposes only. Not for human use.













